SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001570562-21-000173
Filing Date
2021-11-02
Accepted
2021-11-02 16:01:40
Documents
63
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q eols-20210930.htm   iXBRL 10-Q 1752471
2 EX-31.1 exhibit311q32021.htm EX-31.1 10699
3 EX-31.2 exhibit312q32021.htm EX-31.2 10708
4 EX-32.1 exhibit321q32021.htm EX-32.1 7377
  Complete submission text file 0001570562-21-000173.txt   7387533

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eols-20210930.xsd EX-101.SCH 38648
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eols-20210930_cal.xml EX-101.CAL 74354
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eols-20210930_def.xml EX-101.DEF 292223
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eols-20210930_lab.xml EX-101.LAB 596032
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eols-20210930_pre.xml EX-101.PRE 420876
10 EXTRACTED XBRL INSTANCE DOCUMENT eols-20210930_htm.xml XML 1088939
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

IRS No.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38381 | Film No.: 211371094
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences